1-8 of 8
C. Aul
Close
Sort by
Journal Articles

Allogeneic (Allo-) or Autologous (Auto-) Peripheral Blood Stem Cell Transplantation (SCT) Randomized Versus a Second Intensive Consolidation after a Common Induction and Consolidation Course in Patients with Bad Prognosis Myelodysplastic Syndromes and Acute Myelogenous Leukemia Following MDS of More Than 6 Months Duration: The Final Analysis of a Joint Study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups.

T.M. De Witte, MD, A. Hagemeijer, MD, S. Suciu, PhD, A. Belhabri, MD, M. Delforge, MD, C. Aul, MD, M. Aivado, MD, D. Selleslag, MD, H. Schouten, MD, A. Ferrant, MD, H. Biersack, MD, S. Amadori, MD, P. Muus, MD, U. Jehn, MD, F. Beeldens, J. Jansen, PhD, E. Hellstrom-Lindberg, MD, T. Kovacsovics, MD, U. Hess, MD, P. Wijermans, MD, G. Ossenkoppele, MD, A. Gratwohl, MD, J.-P. Marie, MD, R. Willemze, MD
Journal: Blood
Blood (2005) 106 (11): 794.
https://doi.org/10.1182/blood.V106.11.794.794
Published: 2005
Journal Articles

Correlation of Cytogenetic Findings with Morphology, Clinical Course and Prognosis in 2124 Patients with MDS.

D. Haase, C. Steidl, J. Schanz, R. Schabla, M. Pfeilstöcker, T. Nösslinger, B. Hildebrandt, A. Kuendgen, M. Lübbert, B. Kunzmann, A. Giagounidis, C. Aul, L. Trümper, O. Krieger, C. Fonatsch, P. Valent, R. Stauder, U. Germing
Journal: Blood
Blood (2005) 106 (11): 787.
https://doi.org/10.1182/blood.V106.11.787.787
Published: 2005
Journal Articles

A New Prognostic Disease Specific Model To Predict Survival after Intensive Antileukemic Treatment for Young Patients with Poor-Risk MDS and AML: Results of the CRIANT and AML-10 Studies Conducted by the EORTC/GIMEMA/SAKK/HOVON/EBMT Groups.

M. Oosterveld, MD, S. Suciu, M.Sc, P. Muus, MD, M. Delforge, MD, A. Belhabri, MD, C. Aul, MD, D. Selleslag, MD, A. Ferrant, MD, J.-P. Marie, MD, S. Amadori, MD, U. Jehn, MD, U. Hess, MD, R. Willemze, MD, E. Hellstrom-Lindberg, MD, M. Vignetti, MD, B. Labar, MD, F. Mandelli, MD, T. De Witte, MD
Journal: Blood
Blood (2004) 104 (11): 2020.
https://doi.org/10.1182/blood.V104.11.2020.2020
Published: 2004
Journal Articles

Improved outcome in adult B-cell acute lymphoblastic leukemia

D Hoelzer, WD Ludwig, E Thiel, W Gassmann, H Loffler, C Fonatsch, H Rieder, G Heil, B Heinze, R Arnold, D Hossfeld, T Buchner, P Koch, M Freund, W Hiddemann, G Maschmeyer, A Heyll, C Aul, T Faak, R Kuse, TH Ittel, M Gramatzki, H Diedrich, K Kolbe, K Uberla
Journal: Blood
Blood (1996) 87 (2): 495–508.
https://doi.org/10.1182/blood.V87.2.495.bloodjournal872495
Published: 1996
Journal Articles

All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study

C Aul, V Runde, N Gattermann
Journal: Blood
Blood (1993) 82 (10): 2967–2974.
https://doi.org/10.1182/blood.V82.10.2967.2967
Published: 1993
Journal Articles

Comparison of in vitro growth characteristics of blast cell progenitors (CFU-L) in patients with myelodysplastic syndromes and acute myeloid leukemia

C Aul, N Gattermann, W Schneider
Journal: Blood
Blood (1992) 80 (3): 625–633.
https://doi.org/10.1182/blood.V80.3.625.625
Published: 1992
Journal Articles

All-trans retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia [letter; comment]

V Runde, C Aul, A Heyll, W Schneider
Journal: Blood
Blood (1992) 79 (2): 534–535.
https://doi.org/10.1182/blood.V79.2.534.534
Published: 1992
Journal Articles

Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin [letter; comment]

A Heyll, C Aul, V Runde, M Arning, W Schneider, P Wernet
Journal: Blood
Blood (1991) 77 (4): 906.
https://doi.org/10.1182/blood.V77.4.906.906
Published: 1991